Ergomed appoints Lewis Cameron as COO
Pharmaceutical industry services provider Ergomed appointed Lewis Cameron as its next chief operating officer on Monday, effective immediately.
Cameron, who joins Ergomed from the CRO division of Laboratory Corporation Holdings of America, praised the AIM-listed group for its "highly differentiated offering" in the clinical services marketplace and told investors he believed there were "significant opportunities" to build further on the company's growth trajectory.
Chairman Miroslav Reljanović said: "We are delighted to further strengthen our management team with Lewis's appointment.
"He will take on operational responsibility across our whole business and I have no doubt we will benefit from his considerable operational expertise, M&A experience and proven track record of growth across the pharmaceutical services sector as we deliver on our strategy."
As of 1035 GMT, Ergomed shares were up 3.04% at 440p.